Intra-cellular therapies expects to report as of dec. 31, 2019, cash, cash equivalents & investment securities of about $224 mln

Intra-cellular therapies - expect to report as of december 31, 2019, cash, cash equivalents and investment securities of approximately $224 million.

ITCI Ratings Summary

ITCI Quant Ranking